# FDA Inspection 1257125 - Vitalant - December 11, 2024

Source: https://www.keypedia.com/records/fda_inspections/vitalant/afedd455-e470-46c4-bf2f-4a922a676bce
Source feed: FDA_Inspections

> FDA Inspection 1257125 for Vitalant on December 11, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257125
- Company Name: Vitalant
- Inspection Date: 2024-12-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1257125 - 2024-12-11](https://www.keypedia.com/records/fda_inspections/vitalant/83e03f19-feca-4744-a13c-997522957530)
- [FDA Inspection 1210678 - 2023-06-29](https://www.keypedia.com/records/fda_inspections/vitalant/14da869c-9082-46d1-a58c-0f963677bcd6)
- [FDA Inspection 1101143 - 2019-08-14](https://www.keypedia.com/records/fda_inspections/vitalant/68dbc398-8f54-415d-ac8e-2e37d65d46c2)
- [FDA Inspection 920722 - 2015-04-02](https://www.keypedia.com/records/fda_inspections/vitalant/c5502dde-122e-44d8-890d-079b61a3eda5)
- [FDA Inspection 820604 - 2013-02-28](https://www.keypedia.com/records/fda_inspections/vitalant/9855e79c-d989-491e-b268-370dffeed4f6)

Company: https://www.keypedia.com/companies/vitalant/c2148211-e799-40ad-b50d-ac838967a826

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d